<DOC>
	<DOCNO>NCT01445860</DOCNO>
	<brief_summary>The purpose study estimate effect multiple oral dos PF-03882845 pharmacokinetics simvastatin simvastatin acid healthy , adult subject .</brief_summary>
	<brief_title>Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Healthy male and/or female nonchildbearing potential age 18 ( 21 base countryspecific age consent ) 60 year , inclusive , Screening . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical/safety laboratory test . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 inclusive ; total body weight &gt; 50 kg ( 110 lb ) . Use CYP3A4 inhibitor ( eg , ketoconazole , ciprofloxacin , diltiazem ) inducer ( eg , pheytoin , carbamazepine ) substrate ( eg , simvastatin , quinidine ) within 28 day 5 halflives ( whichever longer ) prior Day 1 . Known history hypersensitivity , allergy , severe adverse drug reaction intolerance simvastatin statin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>DDI</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>